Rare and common epilepsies converge on a shared gene regulatory network providing opportunities for novel antiepileptic drug discovery.

Andrée Delahaye-DuriezPrashant SrivastavaKirill ShkuraSarah R LangleyLiisi LaanisteAida Moreno-MoralBénédicte DanisManuela MazzuferiPatrik FoerchElena V GazinaKay RichardsSteven PetrouRafal M KaminskiEnrico PetrettoMichael R Johnson

Published in: Genome biology (2016)

Taken together, our results suggest targeting the expression of M30 as a potential new therapeutic strategy in epilepsy.

Keyphrases

drug discovery
poor prognosis
cancer therapy
binding protein
human health
long non coding rna
risk assessment